Form 4: OS Therapies Inc. Insider Sells Shares in Multiple Transactions

Shalom Auerbach, a director and 10% owner of OS Therapies Inc., sold shares of common stock in multiple transactions on April 9th and 10th, 2025.

Summary

• Shalom Auerbach, a director and 10% owner of OS Therapies Inc. (OSTX), has reported the sale of common stock.
• On April 9, 2025, Auerbach sold 50,012 shares at a weighted average price of $1.353 per share.
• On April 10, 2025, Auerbach sold 10,000 shares at a price of $1.39 per share.
• These sales were executed by Einodmil LLC, where Auerbach serves as the Principal and exercises voting and dispositive power over the shares.
• Following these transactions, Auerbach indirectly beneficially owns 2,746,199 shares through Einodmil LLC.
• The sales occurred at prices ranging from $1.33 to $1.42 per share on April 9th.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider trading activity. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the buying and selling activities of company insiders. It's important for investors to monitor these filings as they can provide insights into management's perspective on the company's valuation and future prospects.

Stakeholder Impact

• Shareholders may react to the insider selling activity, potentially impacting the stock price.
• The transactions provide transparency to the market regarding insider activity.

Key Dates

Keywords

Form 4, Insider Trading, Share Sale, OS Therapies Inc, OSTX, Auerbach, Einodmil LLC, Beneficial Ownership